The National Drug Law Enforcement Agency (NDLEA), Murtala Muhammed International Airport (MMIA) Strategic Command, Ikeja, has seized over nine tonnes of illicit drugs, arrested 260 suspects and secured the conviction of 101 offenders from 2025 till date.
The Commander of the MMIA Strategic Command, Mr Mohammad Ahmad, disclosed this on Friday during the command’s commemoration of the International Day Against Drug Abuse and Illicit Trafficking.
According to him, the command seized 9,058.543 kilograms of illicit drugs within the period through innovative drug law enforcement strategies.
The event had the theme, “World Drug Problem: Persisting Issues, New Challenges, Innovative Responses”.
Ahmad said that the command had continued to achieve significant successes through innovative drug law enforcement strategies.
He said the achievements underscored the command’s commitment to safeguarding the nation from the menace of drug abuse and trafficking.
He called for sustained collaboration among government agencies, communities and other stakeholders to tackle challenges posed by drug trafficking.
In her remarks, retired Assistant Commander-General of Narcotics Ibiba Odili urged Nigerians to support anti-drug campaigns.
Odili said that collective action remained essential in addressing the growing threat of substance abuse and drug trafficking.
One of the participants, Miss Chibuzor Osakwe, stressed the importance of continuous public enlightenment on the dangers of drug abuse and trafficking.
She said that the youth, particularly, would need to understand the consequences of illicit drug use and the need to make healthy and responsible life choices.
According to reports, the International Day Against Drug Abuse and Illicit Trafficking has been observed annually on June 26 since 1989.
It is aimed by the United Nations to raise awareness against drug abuse and illegal drug trade.
The 2026 edition seeks to strengthen global cooperation in preventing drug abuse, combating drug trafficking and promoting effective and innovative responses to emerging drug-related challenges.